A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists

1 The interaction between non-peptide antagonists and the human angiotensin II type 1 (AT 1) receptor in CHO-K1 cells was investigated by incubating the cells with antagonist, followed by a brief exposure to angiotensin II and measurement of the resulting inositol phosphate accumulation. The experim...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical pharmacology 2001-02, Vol.61 (3), p.277-284
Hauptverfasser: Vauquelin, Georges, Morsing, Peter, Fierens, Frederik L.P, De Backer, Jean-Paul, Vanderheyden, Patrick M.L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1 The interaction between non-peptide antagonists and the human angiotensin II type 1 (AT 1) receptor in CHO-K1 cells was investigated by incubating the cells with antagonist, followed by a brief exposure to angiotensin II and measurement of the resulting inositol phosphate accumulation. The experimental data, expressed either as angiotensin II concentration–response curves or as antagonist concentration–inhibition curves, were in good agreement with computer-generated data according to a single-state model for the surmountable antagonist losartan and according to a two-step, two-state receptor model for the insurmountable antagonists candesartan, EXP3174, and irbesartan. Experimental and computer-generated data concerning the simultaneous exposure of the receptors to EXP3174 and losartan indicated that losartan produced a concentration-dependent restoration of the maximal response (angiotensin II concentration–response curves) as well as a rightward shift of the insurmountable portion of the EXP3174 inhibition curves, thus counteracting the higher-affinity EXP3174 binding. In conclusion, these findings provide further support for the concept that insurmountable and surmountable AT 1 antagonists are mutually competitive and that insurmountable antagonist–receptor complexes may adopt different states.
ISSN:0006-2952
1873-2968
DOI:10.1016/S0006-2952(00)00546-3